Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
valeria.bruno@uniroma1.it
Valeria Maria Gloria Bruno
Professore Ordinario
Struttura:
DIPARTIMENTO DI FISIOLOGIA E FARMACOLOGIA "VITTORIO ERSPAMER"
E-mail:
valeria.bruno@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease
BRAIN SCIENCES
2020
The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2020
Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H2S-Producing Enzymes in Multiple Sclerosis
ANTIOXIDANTS
2020
Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia
FRONTIERS IN PSYCHIATRY
2019
Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status
EXPERT OPINION ON THERAPEUTIC TARGETS
2019
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia
FRONTIERS IN PSYCHIATRY
2019
Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system
NEUROPHARMACOLOGY
2018
Dickkopf-3 causes neuroprotection by inducing vascular endothelial growth factor
FRONTIERS IN CELLULAR NEUROSCIENCE
2018
mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
SCIENTIFIC REPORTS
2018
Metabotropic glutamate receptor involvement in the pathophysiology of amyotrophic lateral sclerosis: new potential drug targets for therapeutic applications
CURRENT OPINION IN PHARMACOLOGY
2018
Editorial overview: Neurosciences: Metabotropic glutamate receptors: still promising drug targets for CNS disorders
CURRENT OPINION IN PHARMACOLOGY
2018
Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor
FRONTIERS IN CELLULAR NEUROSCIENCE
2018
Dickkopf-3 upregulates VEGF in cultured human endothelial cells by activating activin receptor-like Kinase 1 (ALK1) Pathway
FRONTIERS IN PHARMACOLOGY
2017
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
MOLECULAR PAIN
2017
Vasorelaxing action of the kynurenine metabolite, xanthurenic acid: the missing link in endotoxin-induced hypotension?
FRONTIERS IN PHARMACOLOGY
2017
Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
NEUROSCIENCE
2017
Alterations in the α2δ ligand, thrombospondin-1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies
EPILEPSIA
2017
Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling
NEUROPHARMACOLOGY
2017
Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia
MOLECULAR BRAIN
2017
Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling
NEUROPHARMACOLOGY
2017
« prima
< precedente
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma